Annual Operating Expenses
$185.72 M
+$48.84 M+35.68%
31 December 2023
Summary:
Pliant Therapeutics annual total operating expenses is currently $185.72 million, with the most recent change of +$48.84 million (+35.68%) on 31 December 2023. During the last 3 years, it has risen by +$102.26 million (+122.53%). PLRX annual operating expenses is now at all-time high.PLRX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$62.01 M
+$1.38 M+2.27%
30 September 2024
Summary:
Pliant Therapeutics quarterly total operating expenses is currently $62.01 million, with the most recent change of +$1.38 million (+2.27%) on 30 September 2024. Over the past year, it has increased by +$14.33 million (+30.05%). PLRX quarterly operating expenses is now at all-time high.PLRX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLRX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.7% | +30.1% |
| 3 y3 years | +122.5% | +115.9% |
| 5 y5 years | +500.8% | +364.1% |
PLRX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +122.5% | at high | +133.2% |
| 5 y | 5 years | at high | +500.8% | at high | +364.1% |
| alltime | all time | at high | +500.8% | at high | +364.1% |
Pliant Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $62.01 M(+2.3%) |
| June 2024 | - | $60.64 M(+15.7%) |
| Mar 2024 | - | $52.39 M(+11.4%) |
| Dec 2023 | $185.72 M(+35.7%) | $47.04 M(-1.4%) |
| Sept 2023 | - | $47.69 M(+0.2%) |
| June 2023 | - | $47.58 M(+9.6%) |
| Mar 2023 | - | $43.43 M(+10.3%) |
| Dec 2022 | $136.88 M(+30.2%) | $39.37 M(+17.8%) |
| Sept 2022 | - | $33.43 M(-3.5%) |
| June 2022 | - | $34.63 M(+17.6%) |
| Mar 2022 | - | $29.46 M(+10.8%) |
| Dec 2021 | $105.11 M | $26.60 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $28.72 M(+16.3%) |
| June 2021 | - | $24.69 M(-1.6%) |
| Mar 2021 | - | $25.09 M(+6.9%) |
| Dec 2020 | $83.46 M(+43.2%) | $23.48 M(+9.3%) |
| Sept 2020 | - | $21.48 M(+4.4%) |
| June 2020 | - | $20.58 M(+14.8%) |
| Mar 2020 | - | $17.93 M(+20.9%) |
| Dec 2019 | $58.28 M(+88.5%) | $14.83 M(+11.0%) |
| Sept 2019 | - | $13.36 M(-15.1%) |
| June 2019 | - | $15.74 M(+9.7%) |
| Mar 2019 | - | $14.35 M |
| Dec 2018 | $30.91 M | - |
FAQ
- What is Pliant Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Pliant Therapeutics?
- What is Pliant Therapeutics annual operating expenses year-on-year change?
- What is Pliant Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly operating expenses year-on-year change?
What is Pliant Therapeutics annual total operating expenses?
The current annual operating expenses of PLRX is $185.72 M
What is the all time high annual operating expenses for Pliant Therapeutics?
Pliant Therapeutics all-time high annual total operating expenses is $185.72 M
What is Pliant Therapeutics annual operating expenses year-on-year change?
Over the past year, PLRX annual total operating expenses has changed by +$48.84 M (+35.68%)
What is Pliant Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of PLRX is $62.01 M
What is the all time high quarterly operating expenses for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly total operating expenses is $62.01 M
What is Pliant Therapeutics quarterly operating expenses year-on-year change?
Over the past year, PLRX quarterly total operating expenses has changed by +$14.33 M (+30.05%)